Regional Urology offers our patients state of the art facilities with access to cutting edge technology and services....
Click Here
BPH Relief. In Sight.
Learn more about the new UroLift System
MonaLisa Touch®: A Novel Vaginal Laser Therapy for Vaginal Health
Click HereLearn about the minimally invasive alternative to surgery.
Click Here
Approximately 15% of couples are unable to conceive after one year of unprotected intercourse...
Click HereOur diverse team of Urologists, Radiation Oncologist, Radiologist, Physician Assistant, and Nurses are here to provide you with the most up to date, personalized Urologic care available in the world. Meet our team and learn more about us.
Read More
Watch the interview between Dr. Chris Cefalu and Ronnie Humphrey as they talk about the local chapter of UsToo, the prostate cancer support group, and the Blue Man Run! Text
View Project09
Apr
We will be hosting a free seminar on February 7, 2018 in Natchitoches, LA to inform and educate the community on many topics regarding Erectile Dysfunction. Text
31
Jan
Regional Urology continues to stay on the forefront of new procedures and technology, and the installation of their new MRI is no exception. The Magnetic Resonance Imaging (MRI) is a diagnostic tool used for non-invasive imaging and will be instrumental in providing a more accurate and timely diagnoses of diseases and ailments ranging from prostate cancer to ruptured tendons in the foot.
The MRI installed at Regional Urology is a Philips Achieva 3.0T, which is the most powerful MRI in the Ark-La-Tex. A 3.0T has a greater signal-to-noise ratio, which generates a higher quality image than its 1.5T counterparts. Dr. Kurt Grozinger, Radiologist for Regional Urology, agrees that “a 3 Tesla magnet provides the optimal imaging parameters in diagnosing prostate carcinoma.” Clearer images lead to more accurate diagnoses which in turn saves more lives. This was the driving reason that Regional Urology chose a 3.0T over the more common 1.5T MRI.
The MRI in the Regional Urology Oncology and Radiation Center at 301 Bert Kouns is fully accredited by the American College of Radiology (ACR). ACR accredited machines are held to a higher standard of compliance and quality assurance to insure patients are being scanned optimally to produce the best image results.
Regional Urology is accepting outside referral scans and is currently able to image abdomen, ankle, brain, foot, pelvis, prostate, lumbar spine, and thoracic spine. If you or your physician would like to schedule a scan at Regional Urology, please call 318-683-0411.
Text View Project24
Jan
A new study released 1/8/2018 suggests that prolonged use of high dose Ibuprofen in adult men might have a negative effect on testicular health.
Text View Project09
Jan
SHREVEPORT UROLOGIST, DR. BRIAN MAZZARELLA OF REGIONAL UROLOGY, NAMED UROLIFT® CENTER OF EXCELLENCE
Designation Recognizes Commitment to Exemplary Care, Deep UroLift Experience
SHREVEPORT, LA – MAY 31, 2017 – Regional Urology of Shreveport, LA today announced that Dr. Brian Mazzarella, M.D. has been named a UroLift® Center of Excellence. He is the first physician in the state of Louisiana to achieve such an honor. This recognition is based on his commitment to exemplary care for men suffering from urinary tract symptoms and his high level of training and experience with the UroLift System in treating men with Benign Prostatic Hyperplasia or BPH.
“The introduction of the UroLift System as a treatment option for men with enlarged prostate has fundamentally changed how I treat this condition. Patients finally have a safe and simple alternative to procedures that involve cutting, heating, or removal of prostate tissue,” said Dr. Mazzarella. “The UroLift System is a minimally invasive treatment option that typically allows patients to discontinue taking medications and doesn’t interfere with sexual function. I am honored to be leading the state of Louisiana by offering this breakthrough procedure that betters the lives of many.”
The UroLift System is a proven treatment that can get men off BPH medications and allows them to avoid major surgery, while preserving sexual function. Long-term clinical data from the LIFT randomized study published in Urologic Clinics of North America showed that, after four years, patients treated with the UroLift device continue to experience symptom relief with minimal side effects, with few patients requiring an additional procedure for relief. A second randomized clinical trial called BPH6 demonstrated that the minimally invasive UroLift device compares very well to the reference standard surgery, transurethral resection of the prostate (TURP), with regard to efficacy, and is superior to TURP at preserving sexual function and offering a more rapid recovery.
More than 37 million men in the United States are affected by BPH. Not to be confused with prostate cancer, BPH occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include sleepless nights and urinary problems, and can cause loss of productivity, depression and decreased quality of life.
Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction and retrograde ejaculation.
To schedule a consultation with Dr. Mazzarella, please call 318-683-0411.
About the UroLift System
NeoTract Inc.’s FDA-cleared UroLift System is a novel, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function. Patients also experienced a significant improvement in quality of life. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The UroLift System is available in the U.S., Europe, Australia and Canada. Learn more at www.UroLift.com.
Text View Project25
JulThe MonaLisa Touch® Vaginal Laser offers revolutionary FDA approved relief of vaginal discomfort, itching, dryness, painful intercourse and other symptoms experienced by perimenopausal, menopausal or post cancer patients! Text
View Project05
MayAre you or a loved one affected by Prostate Cancer? Us TOO! Join us for our next meeting of the Us TOO: Shreveport/Bossier City Prostate Cancer Support Group. Food and drinks will be provided. Text
View Project05
MayRegional Urology is pleased to offer the first fellowship trained male fertility specialist in the Ark-La-Tex. Dr. Jared Moss joined RegionalUrology in August 2016 after completing his male fertility fellowship at Northwestern Memorial Hospital in Chicago, IL. Urologist who have completed this type of training are very rare and make up approximately 1% of urologist is the U.S. Text
View Project29
AprFill out the form below to request to be contacted for an appointment
Contact Us Today
318-683-0411
